전남대학교 중앙도서관

  • 중앙도서관
  • 여수캠퍼스도서관
  • 법학도서관
  • 치의학도서관
  • 의학도서관

링크메뉴

  • 화면키우기 화면줄이기 화면크기 원래대로
  • S
  • HOME
  • 로그인
  • 전남대
  • ENG
  • CHN

주메뉴

전체메뉴

전자자료 상세검색

전자자료 상세검색

통합검색
상세검색
검색어 [키워드: "Margaritopoulos, G"]
총 73건 
※ 페이지 이동 시, 중복 레코드가 제거되므로 초기 검색결과 수와 차이가 있을 수 있습니다.
5/8 페이지 RSS 엑셀파일 출력
검색결과수정
  • 검색범위확장
    • Full Text내 키워드 확장
    • 관련 주제어 확장

    재검색

  • 검색결과제한
    • 원문(Full Text)
    • Peer-Reviewed 학술지
    • 발행년 -

    재검색

  • 자료유형
    • Academic Journals (70)
    • Magazines (3)

    재검색

  • 주제
    • idiopathic pulmonary fibrosis (13)
    • pulmonary fibrosis (11)
    • lung diseases, interstitial (9)

    더보기

    재검색

  • 간행물
    • american journal of respiratory and critical care medicine (14)
    • thorax (13)
    • arthritis & rheumatology (10)

    더보기

    재검색

  • 출판사
    • amer thoracic soc (12)
    • bmj publishing group (11)
    • wiley-blackwell (8)

    더보기

    재검색

  • 언어
    • english (70)
    • portuguese (1)

    재검색

  • Publication Year
    • 2016 (1)
    • 2017 (1)

    재검색

  • 수록데이터베이스
    • Science Citation Index Expanded (32)
    • MEDLINE (26)
    • Journals@OVID (3)

    더보기

    재검색

  • PQDTSearch
  • CAJSearch
  • RISSSearch
  • PsycINFOSearch

 

41
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study. 미리보기

학술저널

issue
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2020 Dec 15; Vol. 202 (12), pp. 1656-1665.
Author
Drake TM; Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
Docherty AB; Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
Harrison EM; Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
Quint JK; National Heart and Lung Institute, Imperial College, London, United Kingdom.
Adamali H; Bristol Interstitial Lung Disease Service, North Bristol NHS Trust and.; Academic Respiratory Unit, University of Bristol, Southmead Hospital, Bristol, United Kingdom.
Agnew S; Liverpool Interstitial Lung Disease Service, Aintree site, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
Babu S; Queen Alexandra Hospital, Portsmouth, United Kingdom.
Barber CM; Northern General Hospital, Sheffield, United Kingdom.
Barratt S; Bristol Interstitial Lung Disease Service, North Bristol NHS Trust and.; Academic Respiratory Unit, University of Bristol, Southmead Hospital, Bristol, United Kingdom.
Bendstrup E; Centre for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.
Bianchi S; Northern General Hospital, Sheffield, United Kingdom.
Villegas DC; Interstitial Lung Disease (ILD) Unit, Respiratory Medicine Department, Hospital of the Holy Cross and Saint Paul, Barcelona, Spain.
Chaudhuri N; ILD Unit, Manchester University Hospital NHS Foundation Trust, Wythenshawe Hospital, Wythenshawe, United Kingdom.; University of Manchester, Manchester, United Kingdom.
Chua F; Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
Coker R; Respiratory Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Chang W; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
Crawshaw A; Birmingham Interstitial Lung Disease Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
Crowley LE; University of Birmingham, Birmingham, United Kingdom.
Dosanjh D; Birmingham Interstitial Lung Disease Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
Fiddler CA; Cambridge Interstitial Lung Disease Service, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.
Forrest IA; Department of Respiratory Medicine, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
George PM; National Heart and Lung Institute, Imperial College, London, United Kingdom.; Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
Gibbons MA; South West Peninsula ILD Network, Royal Devon & Exeter Foundation NHS Trust, Exeter, United Kingdom.
Groom K; Respiratory Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Haney S; Northumbria Specialist Emergency Care Hospital, Northumbria Healthcare NHS Foundation Trust, Cramlington, United Kingdom.
Hart SP; Respiratory Research Group, Hull York Medical School, Castle Hill Hospital, Cottingham, United Kingdom.
Heiden E; University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom.
Henry M; Cork University Hospital, Cork, Ireland.
Ho LP; Oxford Interstitial Lung Disease Service, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Hoyles RK; Oxford Interstitial Lung Disease Service, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Hutchinson J; King's Mill Hospital, Nottinghamshire, United Kingdom.
Hurley K; Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.; Beaumont Hospital, Dublin, Ireland.
Jones M; University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom.; National Institute for Health Research (NIHR) Southampton Biomedical Research Centre & Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.
Jones S; Action for Pulmonary Fibrosis, Stuart House, Peterborough, United Kingdom.
Kokosi M; Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.; Guys and St. Thomas' NHS Trust, London, United Kingdom.
Kreuter M; Center for Interstitial and Rare Lung Diseases, Pneumology, Thoraxklinik, University of Heidelberg and German Center for Lung Research, Heidelberg, Germany.
MacKay LS; Northumbria Specialist Emergency Care Hospital, Northumbria Healthcare NHS Foundation Trust, Cramlington, United Kingdom.
Mahendran S; Kingston Hospital NHS Foundation Trust, Surrey, United Kingdom.
Margaritopoulos G; ILD Unit, Manchester University Hospital NHS Foundation Trust, Wythenshawe Hospital, Wythenshawe, United Kingdom.
Molina-Molina M; ILD Unit, Respiratory Department, University Hospital of Bellvitge, Institut d'Investigació Biomèdica de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
Molyneaux PL; National Heart and Lung Institute, Imperial College, London, United Kingdom.
O'Brien A; University Hospital Limerick, Limerick, Ireland.
O'Reilly K; Department of Respiratory Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.
Packham A; Birmingham Interstitial Lung Disease Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
Parfrey H; Cambridge Interstitial Lung Disease Service, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.
Poletti V; Centre for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.; Department of Diseases of the Thorax, Morgagni Hospital, Forli, Italy.
Porter JC; UCL Respiratory, University College London and ILD Service, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Renzoni E; Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
Rivera-Ortega P; ILD Unit, Manchester University Hospital NHS Foundation Trust, Wythenshawe Hospital, Wythenshawe, United Kingdom.
Russell AM; National Heart and Lung Institute, Imperial College, London, United Kingdom.; Imperial Healthcare NHS Trust, St. Mary's Hospital, The Bays, London, United Kingdom.
Saini G; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
Spencer LG; Liverpool Interstitial Lung Disease Service, Aintree site, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
Stella GM; Laboratory of Biochemistry and Genetics, Pneumology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.
Stone H; University Hospital North Midlands NHS Trust, Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom.
Sturney S; Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom.
Thickett D; Birmingham Interstitial Lung Disease Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.; University of Birmingham, Birmingham, United Kingdom.
Thillai M; Cambridge Interstitial Lung Disease Service, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.
Wallis T; University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom.; National Institute for Health Research (NIHR) Southampton Biomedical Research Centre & Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.
Ward K; National Heart and Lung Institute, Imperial College, London, United Kingdom.
Wells AU; Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
West A; Guys and St. Thomas' NHS Trust, London, United Kingdom.
Wickremasinghe M; Imperial Healthcare NHS Trust, St. Mary's Hospital, The Bays, London, United Kingdom.
Woodhead F; Institute of Lung Health, Interstitial Lung Disease Unit, Glenfield Hospital, Leicester, United Kingdom.
Hearson G; NIHR Biomedical Research Centre, Respiratory Research Unit, University of Nottingham, Nottingham, United Kingdom.
Howard L; NIHR Biomedical Research Centre, Respiratory Research Unit, University of Nottingham, Nottingham, United Kingdom.
Baillie JK; Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.; Intensive Care Unit, Royal Infirmary Edinburgh, Edinburgh, United Kingdom.
Openshaw PJM; National Heart and Lung Institute, Imperial College, London, United Kingdom.
Semple MG; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom; and.; Respiratory Medicine, Alder Hey Children's Hospital, Liverpool, United Kingdom.
Stewart I; NIHR Biomedical Research Centre, Respiratory Research Unit, University of Nottingham, Nottingham, United Kingdom.
Jenkins RG; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.; NIHR Biomedical Research Centre, Respiratory Research Unit, University of Nottingham, Nottingham, United Kingdom.
DB Label
Database : MEDLINE
원문보기
Full Text(ECC)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
42
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact. 미리보기

학술저널

issue
The European respiratory journal [Eur Respir J] 2020 Jul 09; Vol. 56 (1). Date of Electronic Publication: 2020 Jul 09 (Print Publication: 2020).
Author
Bonifazi M; Dept of Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona, Italy bonifazimarti@gmail.com.; Pulmonary Disease Unit, Dept of Internal Medicine, Azienda Ospedali Riuniti, Ancona, Italy.; Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, London, UK.
Sverzellati N; Radiology, Dept of Medicine and Surgery, Università di Parma, Parma, Italy.
Negri E; Dept of Biomedical and Clinical Sciences 'Luigi Sacco', Università degli Studi di Milano, Milan, Italy.
Jacob J; Dept of Respiratory Medicine, University College London, London, UK.; Centre for Medical Image Computing, University College London, London, UK.
Egashira R; Dept of Radiology, Faculty of Medicine, Saga University, Saga city, Japan.
Moser J; Dept of Radiology, St George's University Hospitals NHS Foundation Trust, London, UK.
Piciucchi S; Radiology Unit, Ospedale GB Morgagni, Forlì, Italy.
Mei F; Pulmonary Disease Unit, Dept of Internal Medicine, Azienda Ospedali Riuniti, Ancona, Italy.
De Lauretis A; Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, London, UK.; Pulmonary Diseases Unit, Azienda Ospedaliera 'Guido Salvini', Garbagnate Milanese, Italy.
Visca D; Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, London, UK.; Division of Pulmonary Rehabilitation, Istituti Clinic Scientifici Maugeri, IRCCS, Tradate, Italy.
Goh N; Dept of Respiratory Medicine, Austin Hospital, Melbourne, Australia.; Institute for Breathing and Sleep, Melbourne, Australia.
Bonini M; National Heart and Lung Institute (NHLI), Imperial College London and Royal Brompton Hospital, London, UK.; Dept of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A.Gemelli-IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Cirilli L; Dept of Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona, Italy.
La Vecchia C; Dept of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Chua F; Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, London, UK.
Kouranos V; Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, London, UK.
Margaritopoulos G; Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, London, UK.; Interstitial Lung Disease Unit, Manchester University Hospital NHS FT, Wythenshawe Hospital, Manchester, UK.
Kokosi M; Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, London, UK.
Maher TM; Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, London, UK.
Gasparini S; Dept of Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona, Italy.; Pulmonary Disease Unit, Dept of Internal Medicine, Azienda Ospedali Riuniti, Ancona, Italy.
Gabrielli A; Dept of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
Wells AU; Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, London, UK.
Renzoni EA; Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, London, UK.
DB Label
Database : MEDLINE
원문보기
Full Text(ECC)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
43
Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease. 미리보기

학술저널

issue
Clinical rheumatology [Clin Rheumatol] 2020 Apr; Vol. 39 (4), pp. 1173-1179. Date of Electronic Publication: 2020 Jan 08.
Author
Stock CJW; Interstitial Lung Disease Unit, National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK. c.stock@imperial.ac.uk.
De Lauretis A; Interstitial Lung Disease Unit, National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK.; Unita' Operativa Malattie Respiratorie, Ospedale Guido Salvini, Garbagnate Milanese, Milan, Italy.
Visca D; Interstitial Lung Disease Unit, National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK.; Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy.
Daccord C; Interstitial Lung Disease Unit, National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK.; Division of Respiratory Medicine, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Kokosi M; Interstitial Lung Disease Unit, National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK.
Kouranos V; Interstitial Lung Disease Unit, National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK.
Margaritopoulos G; Interstitial Lung Disease Unit, National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK.
George PM; Interstitial Lung Disease Unit, National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK.
Molyneaux PL; Interstitial Lung Disease Unit, National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK.
Nihtyanova S; Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, London, UK.
Chua F; Interstitial Lung Disease Unit, National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK.
Maher TM; Interstitial Lung Disease Unit, National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK.
Ong V; Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, London, UK.
Abraham DJ; Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, London, UK.
Denton CP; Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, London, UK.
Wells AU; Interstitial Lung Disease Unit, National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK.
Wain LV; Department of Health Sciences, University of Leicester, Leicester, UK.; National Institute for Health Research, Leicester Respiratory Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
Renzoni EA; Interstitial Lung Disease Unit, National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK.
DB Label
Database : MEDLINE
원문보기
등재 - Web of Science (SCIE)  조회 - Impact Factor (JCR) 
44
In patients with idiopathic pulmonary fibrosis the presence of hiatus hernia is associated with disease progression and mortality. 미리보기

사설/의견

issue
The European respiratory journal [Eur Respir J] 2019 May 23; Vol. 53 (5). Date of Electronic Publication: 2019 May 23 (Print Publication: 2019).
Author
Mackintosh JA; Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Desai SR; Royal Brompton and Harefield NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Adamali H; North Bristol NHS Trust, Bristol, UK.
Patel K; Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Chua F; Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Devaraj A; Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Kouranos V; Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Kokosi M; Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Margaritopoulos G; Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Renzoni EA; Royal Brompton and Harefield NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Wells AU; Royal Brompton and Harefield NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Molyneaux PL; Royal Brompton and Harefield NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Kumar S; Royal Marsden Hospital, London, UK.
Maher TM; Royal Brompton and Harefield NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
George PM; Royal Brompton and Harefield NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
DB Label
Database : MEDLINE
원문보기
Full Text(ECC)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
45
Predicting outcomes in rheumatoid arthritis related interstitial lung disease. 미리보기

학술저널

issue
The European respiratory journal [Eur Respir J] 2019 Jan 03; Vol. 53 (1). Date of Electronic Publication: 2019 Jan 03 (Print Publication: 2019).
Author
Jacob J; Dept of Respiratory Medicine, University College London, London, UK.; Centre for Medical Image Computing, University College London, London, UK.
Hirani N; MRC Centre for Inflammation Research, Edinburgh Royal Infirmary, Edinburgh, UK.
van Moorsel CHM; St Antonius ILD Center of Excellence, Dept of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands.; Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands.
Rajagopalan S; Division of Radiology, Mayo Clinic Rochester, Rochester, MN, USA.
Murchison JT; Dept of Radiology, Edinburgh Royal Infirmary, Edinburgh, UK.
van Es HW; Dept of Radiology, St Antonius Hospital, Nieuwegein, The Netherlands.
Bartholmai BJ; Division of Radiology, Mayo Clinic Rochester, Rochester, MN, USA.
van Beek FT; St Antonius ILD Center of Excellence, Dept of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands.
Struik MHL; St Antonius ILD Center of Excellence, Dept of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands.
Stewart GA; Edinburgh Lung Fibrosis Clinic, Edinburgh Royal Infirmary, Edinburgh, UK.
Kokosi M; Interstitial Lung Disease Unit, Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Egashira R; Dept of Radiology, Faculty of Medicine, Saga University, Saga City, Japan.
Brun AL; Imaging Dept, Hôpital Cochin, Paris-Descartes University, Paris, France.
Cross G; Dept of Radiology, Royal Free Hospital NHS Foundation Trust, London, UK.
Barnett J; Dept of Radiology, Royal Brompton Hospital, London, UK.
Devaraj A; Dept of Radiology, Royal Brompton Hospital, London, UK.
Margaritopoulos G; Interstitial Lung Disease Unit, Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Karwoski R; Dept of Physiology and Biomedical Engineering, Mayo Clinic Rochester, Rochester, MN, USA.
Renzoni E; Interstitial Lung Disease Unit, Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Maher TM; Interstitial Lung Disease Unit, Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, UK.; Fibrosis Research Group, National Heart and Lung Institute, Imperial College, London, UK.
Wells AU; Interstitial Lung Disease Unit, Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
DB Label
Database : MEDLINE
원문보기
Full Text(ECC)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
47
miR-185 and miR-29a are similarly expressed in the bronchoalveolar lavage cells in IPF and lung cancer but common targets DNMT1 and COL1A1 show disease specific patterns. 미리보기

학술저널

issue
Molecular medicine reports [Mol Med Rep] 2018 May; Vol. 17 (5), pp. 7105-7112. Date of Electronic Publication: 2018 Mar 19.
Author
Bibaki E; Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, 71110 Heraklion, Crete, Greece.
Tsitoura E; Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, 71110 Heraklion, Crete, Greece.
Vasarmidi E; Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, 71110 Heraklion, Crete, Greece.
Margaritopoulos G; Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, 71110 Heraklion, Crete, Greece.
Trachalaki A; Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, 71110 Heraklion, Crete, Greece.
Koutoulaki C; Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, 71110 Heraklion, Crete, Greece.
Georgopoulou T; Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, 71110 Heraklion, Crete, Greece.
Spandidos DA; Laboratory of Clinical Virology, Medical School, University of Crete, 71003 Heraklion, Crete, Greece.
Tzanakis N; Department of Thoracic Medicine, Interstitial Lung Disease Unit, University Hospital, University of Crete, 71110 Heraklion, Crete, Greece.
Antoniou KM; Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, 71110 Heraklion, Crete, Greece.
DB Label
Database : MEDLINE
원문보기
등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
48
Upregulation of citrullination pathway: From Autoimmune to Idiopathic Lung Fibrosis. 미리보기

학술저널

issue
Respiratory research [Respir Res] 2017 Dec 29; Vol. 18 (1), pp. 218. Date of Electronic Publication: 2017 Dec 29.
Author
Samara KD; Department of Thoracic Medicine and Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Crete, Greece.; Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, London, SW3 6NP, UK.
Trachalaki A; Department of Thoracic Medicine and Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Crete, Greece.
Tsitoura E; Department of Thoracic Medicine and Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Crete, Greece.
Koutsopoulos AV; Department of Pathology, Medical School, University of Crete and Heraklion University Hospital, Heraklion, Crete, Greece.
Lagoudaki ED; Department of Pathology, Medical School, University of Crete and Heraklion University Hospital, Heraklion, Crete, Greece.
Lasithiotaki I; Department of Thoracic Medicine and Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Crete, Greece.
Margaritopoulos G; Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, London, SW3 6NP, UK.
Pantelidis P; Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, London, SW3 6NP, UK.
Bibaki E; Department of Thoracic Medicine and Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Crete, Greece.
Siafakas NM; Department of Thoracic Medicine and Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Crete, Greece.
Tzanakis N; Department of Thoracic Medicine and Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Crete, Greece.
Wells AU; Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, London, SW3 6NP, UK.
Antoniou KM; Department of Thoracic Medicine and Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, Heraklion, Crete, Greece. kantoniou@med.uoc.gr.
DB Label
Database : MEDLINE
원문보기
Full Text Full Text (원문보기) OA (Springer)  Open Access (PubMed Central)  Open Access (BioMed Central)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
49
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study. 미리보기

학술저널

issue
The European respiratory journal [Eur Respir J] 2017 Aug 31; Vol. 50 (2). Date of Electronic Publication: 2017 Aug 31 (Print Publication: 2017).
Author
Walsh SLF; Dept of Radiology, King's College Hospital Foundation Trust, London, UK slfwalsh@gmail.com.
Maher TM; Dept of Respiratory Medicine, Interstitial Lung Disease Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College, London, UK.
Kolb M; Depts of Medicine and Pathology/Molecular Medicine, McMaster University, Firestone Institute for Respiratory Health, Hamilton, ON, Canada.
Poletti V; Department of Diseases of the Thorax, Ospedale GB Morgagni, Forlì, Italy.; Dept of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.
Nusser R; Dept of Respiratory Medicine, Summit Hospital, Oakland, CA, USA.
Richeldi L; Unità Operativa Complessa di Pneumologia, Università Cattolica del Sacro Cuore, Fondazione Policlinico A. Gemelli, Rome, Italy.
Vancheri C; Dept of Clinical and Experimental Medicine, University of Catania, University - Hospital 'Policlinico - Vitt. Emanuele', Catania, Italy.
Wilsher ML; Auckland District Health Board and the University of Auckland, Auckland, New Zealand.
Antoniou KM; Dept of Respiratory Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece.
Behr J; Dept of Medicine V, University of Munich and Asklepios Fachkliniken Gauting, Comprehensive Pneumology Center, member of the German Center for Lung Research, Munich, Germany.
Bendstrup E; Dept of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.
Brown K; National Jewish Health, Denver, CO, USA.
Calandriello L; Institute of Radiology, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.
Corte TJ; Dept of Respiratory Medicine, Royal Prince Alfred Hospital, and University of Sydney, Sydney, Australia.
Cottin V; Service de Pneumologie, Hopital L. Pradel, Lyon, France.
Crestani B; APHP, Hopital Bichat, Service de Pneumologie A, Université Paris Diderot, Paris, France.
Flaherty K; University of Michigan, Division of Pulmonary and Critical Care Medicine, Ann Arbor, MI, USA.
Glaspole I; Alfred Health - Allergy, Immunology and Respiratory Medicine, Melbourne, Australia.
Grutters J; ILD Center of Excellence, St Antonius Hospital, Division Heart and Lungs, University Medical Centre Utrecht, Utrecht, The Netherlands.
Inoue Y; Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.
Kokosi M; Dept of Respiratory Medicine, Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.
Kondoh Y; Tosei General Hospital, Dept of Respiratory Medicine and Allergy, Seto, Japan.
Kouranos V; Dept of Respiratory Medicine, Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.
Kreuter M; Center for interstitial and rare lung diseases, Pneumology and respiratory critical care medicine, Thoraxklinik, University of Heidelberg, and Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research (DZL), Heidelberg, Germany.
Johannson K; University Of Calgary, Calgary, AB, Canada.
Judge E; Respiratory Medicine and National Lung Transplantation Unit, Mater Misericordiae University Hospital, Dublin , Ireland.
Ley B; Medicine, University of California San Francisco, San Francisco, CA, USA.
Margaritopoulos G; Dept of Respiratory Medicine, Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.
Martinez FJ; Weill Cornell Medicine, New York, NY, USA.
Molina-Molina M; University Hospital of Bellvitge-IDIBELL-CIBERES, Barcelona, Spain.
Morais A; Centro Hospitalar São João - Pulmonology, Faculdade de Medicina do Porto, Alameda Professor Hernâni Monteiro, Oporto, Portugal.
Nunes H; Paris 13 University, Sorbonne Paris Cité, Service de Pneumologie, Hopital Avicenne, Bobigny, France.
Raghu G; University of Washington - Center for Interstitial Lung Disease, Seattle, WA, USA.
Ryerson CJ; University of British Columbia - Medicine, Vancouver, BC, Canada.
Selman M; Instituto Nacional de Enfermedades Respiratorias 'Ismael Cosio Villegas', Mexico City, Mexico.
Spagnolo P; Section of Respiratory Diseases, Dept of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy.
Taniguchi H; Tosei General Hospital, Dept of Respiratory Medicine and Allergy, Seto, Japan.
Tomassetti S; Department of Diseases of the Thorax, Ospedale GB Morgagni, Forlì, Italy.
Valeyre D; Paris 13 University, Sorbonne Paris Cité, Service de Pneumologie, Hopital Avicenne, Bobigny, France.
Wijsenbeek M; Dept of Pulmonary Diseases, Erasmus MC, University Hospital Rotterdam, Rotterdam, The Netherlands.
Wuyts W; Respiratory Medicine, University Hospitals Leuven, Leuven, Belgium.
Hansell D; Dept of Thoracic Imaging, Royal Brompton Hospital, London, UK.
Wells A; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.
DB Label
Database : MEDLINE
원문보기
Full Text(ECC)  등재 - Web of Science (SCIE)  등재 - SCOPUS  조회 - Impact Factor (JCR) 
50
Challenges in IPF diagnosis, current management and future perspectives. 미리보기

학술저널

issue
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG [Sarcoidosis Vasc Diffuse Lung Dis] 2015 Aug 03; Vol. 32 Suppl 1, pp. 28-35. Date of Electronic Publication: 2015 Aug 03.
Author
Wells AU; Royal Brompton Hospital, London, UK. redazione@mattioli1885.com.
Costabel U
Poletti V
Crestani B
Egan J
Margaritopoulos G
Antoniou K
DB Label
Database : MEDLINE
원문보기
등재 - Web of Science (SCIE)  조회 - Impact Factor (JCR) 
1 2 3 4 5  
바구니보기

QUICK LINK

  • 희망도서신청
  • 대출/연장조회
  • 서가부재도서
  • 이용교육

마이메뉴추가

QRCode
  • 개인정보호정책
  • 이메일무단수집거부
  • 도서관이용문의

    • 도서관자치위원회  원격제어  Instagram  facebook  w  kakao 플친
500-757 광주광역시 북구 용봉로 77 TEL 062)530-3571~2(대출반납실) FAX 062)530-3529
Copyright@2013 CHONNAM NATIONAL UNIVERSITY LIBRARY, All Rights Reserved.
  • 59147
  • 127070068